Apart from statins, other lipid-lowering drugs (ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors) are recommended in a group of patients for stroke prevention. The gene discussed is PCSK9; the disease is stroke disorder.